Matrix, laser, needle: the plumbing that determines what you see
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 51 of 68 of this archive, newest first.
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
This is the single interaction with ordinary medical care that patients most need to disclose, and it is the one most often not asked about.
The sequence predicts the failure mode. A methionine predicts oxidation; an asparagine followed by a glycine predicts deamidation; a cysteine predicts disulphide scrambling.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
A reminder that a purity figure is the output of a method, and that methods differ.
Peptide bonds absorb strongly near 214 nm; aromatic side chains absorb near 280 nm. A method reading at 280 is blind to any fragment lacking an aromatic residue.
The ceiling varies severalfold between people, and nothing measurable at baseline predicts where it sits.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Estimated glomerular filtration rate is a calculation with muscle mass in the denominator of its assumptions. In this population that matters.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
Efficacy was never the question in this appraisal. Duration of treatment was.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
Why the reason for stopping changes what happens afterwards.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.
The practical difficulty is not knowing the target. It is meeting it on an appetite that has been pharmacologically reduced by half.
Reported from the sessions, and from the two hours afterwards.
The evidence base is thin and the document says so, which is to its credit.
Follow the resin, not the catalogue.
Reported from the analysis, not from a warning notice.